Morgan Stanley Raises iRhythm (IRTC) PT on MedTech Recovery Outlook [Yahoo! Finance]
iRhythm Technologies (NASDAQ:IRTC) had its price target lowered by analysts at Truist Financial Corporation from $230.00 to $215.00. They now have a "buy" rating on the stock.
HALPER SADEH LLC ENCOURAGES IRHYTHM TECHNOLOGIES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm
iRhythm Technologies (NASDAQ:IRTC) had its price target raised by analysts at Morgan Stanley from $195.00 to $205.00. They now have an "overweight" rating on the stock.